CERo Therapeutics Inc.

NASDAQ: CERO · Real-Time Price · USD
7.97
-0.14 (-1.73%)
At close: Aug 15, 2025, 3:59 PM
7.89
-1.07%
After-hours: Aug 15, 2025, 07:49 PM EDT

CERo Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-7.29M -2.54K -667.74K -315.55K
Depreciation & Amortization
1.16M 1.12M 1.07M 735.47K
Stock-Based Compensation
96.9K n/a 381.07K 287.74K
Other Working Capital
1.58M -740.46K 2.41M -365.08K
Other Non-Cash Items
239.31K -254.61K -2.84M -16.48K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
1.84M 540.11K 2.41M -365.08K
Operating Cash Flow
-5.79M -5.79M -1.09M -697.11K
Capital Expenditures
-1 -3 -694.23K -612.57K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a -14.34M -325K -178.5M
Sales Maturities Of Investments
n/a 5.64M n/a n/a
Other Investing Acitivies
n/a 8.69M 181.16M -306K
Investing Cash Flow
n/a -7.94K 180.84M -178.5M
Debt Repayment
-14.18K 564.04K 650K n/a
Common Stock Repurchased
n/a -33.48K -139.35M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
571.68K -33.55K -139.21M 60.26K
Financial Cash Flow
571.68K 571.68K -138.7M 180.3M
Net Cash Flow
-5.22M -5.22M 41.04M -28.77M
Free Cash Flow
-5.79M -5.79M -1.79M -1.31M